The most common question from men currently receiving TRT through telehealth: "If the rules change, am I grandfathered in?" The answer involves more legal nuance than a simple yes or no — but the general direction is reassuring for established patients.
What "Grandfathering" Means Legally
In regulatory contexts, grandfathering refers to provisions that exempt existing arrangements from new rules. The concept recognizes that retroactively disrupting established relationships creates harm that outweighs the regulatory benefit of universal application.
For telehealth TRT, the grandfathering question asks: if the DEA requires in-person examinations for new controlled substance prescriptions via telehealth, do men who already have an established telehealth prescribing relationship need to comply with the new requirement?
The DEA's Proposed Approach
The DEA's proposed rulemaking for telehealth controlled substance prescribing included provisions for existing patients. The key elements from the proposed framework:
- Established relationship recognition: Patients who received a valid controlled substance prescription under the COVID-era flexibilities would be recognized as having an established prescriber-patient relationship.
- Continuation of care: Prescribers with established patient relationships could continue prescribing via telehealth under transitional provisions, even after new rules take effect.
- Transition period: A grace period (proposed as 180 days in early drafts) would allow existing patients to complete an in-person visit if ultimately required, rather than facing immediate prescription disruption.
These provisions haven't been finalized — the final rule hasn't been published. But the proposed direction strongly favors protecting existing patients.
The State Law Layer
Federal DEA rules set the floor, but many states have enacted their own telehealth prescribing laws that may provide additional protections. Some states have permanently adopted telehealth prescribing authority for controlled substances through state legislation, which operates independently of the DEA waiver.
If your state has enacted permanent telehealth controlled substance prescribing authority — and your prescriber is licensed in your state — state law may provide an independent legal basis for continuing your telehealth TRT relationship regardless of what happens with the federal waiver.
What "Established Relationship" Actually Requires
Elements of an Established Prescriber-Patient Relationship
- Prior prescription: At least one controlled substance prescription has been issued by the prescriber to the patient
- Medical evaluation: A clinical evaluation (even via telehealth under the waiver) was conducted before prescribing
- Ongoing monitoring: The prescriber has conducted follow-up evaluations and lab review as part of ongoing care
- Documentation: Medical records documenting the relationship, evaluations, and prescribing history exist in the prescriber's records
If all four elements are present, you have a documented, established prescriber-patient relationship that provides the strongest basis for continued telehealth prescribing under any foreseeable regulatory framework.
What You Should Do Now
- Confirm your records are complete: Your telehealth platform should have documented consultations, lab results, and prescription history. Request a copy for your own records.
- Ensure monitoring is current: If you've been skipping follow-up labs or consultations, catch up now. A well-documented, actively monitored relationship is stronger than a passive subscription.
- Stay with your current prescriber if satisfied: Switching platforms right before a regulatory transition means starting a new relationship — potentially one that hasn't been established long enough to qualify for grandfathering.
The Bottom Line
Existing Patients Are Well-Positioned
Both the DEA's proposed rulemaking and general regulatory precedent favor protecting established prescriber-patient relationships. Men currently receiving TRT through telehealth with documented evaluations, labs, and ongoing monitoring are in the strongest position. The most important action: ensure your medical records are complete and your monitoring is current. A well-documented relationship is your best protection against any regulatory change.